Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study

Chun, 2006, Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology, Eur Urol, 49, 820, 10.1016/j.eururo.2005.11.007 Smeenge, 2012, Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a consensus panel, BJU Int, 110, 942, 10.1111/j.1464-410X.2012.11072.x Scattoni, 2010, Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy, Eur Urol, 57, 1, 10.1016/j.eururo.2009.08.011 Ukimura, 2013, Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care, Eur Urol, 63, 214, 10.1016/j.eururo.2012.09.033 Barentsz, 2012, ESUR prostate MRguidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Heidenreich, 2014, EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer, Eur Urol, 65, 467, 10.1016/j.eururo.2013.11.002 Scattoni, 2007, Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature, Eur Urol, 52, 1309, 10.1016/j.eururo.2007.08.006 Sciarra, 2011, Advances in magnetic resonance imaging: how they are changing the management of prostate cancer, Eur Urol, 59, 962, 10.1016/j.eururo.2011.02.034 Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009 Panebianco, 2013, Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging, Eur Radiol, 23, 1745, 10.1007/s00330-013-2768-3 Panebianco, 2013, Metabolic atrophy and 3T 1H—MR spectroscopy correlation after radiation therapy for prostate cancer, BJU Int Thompson, 2013, The role of magnetic resonance imaging in the diagnosis and management of prostate cancer, BJU Int, 112, 6, 10.1111/bju.12381 Somford, 2013, Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer, Invest Radiol, 48, 152, 10.1097/RLI.0b013e31827b711e Turkbey, 2013, Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?, Radiology, 268, 144, 10.1148/radiol.13121325 Panebianco, 2013, In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR diffusion tensor imaging, Eur J Radiol, 82, 1677, 10.1016/j.ejrad.2013.05.013 Claus, 2004, Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy, Radiographics, 24, S167, 10.1148/24si045516 Kobus, 2012, Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3T, Radiology, 265, 457, 10.1148/radiol.12111744 Hambrock, 2012, Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort, Eur Urol, 61, 177, 10.1016/j.eururo.2011.08.042 Pokorny, 2014, Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies, Eur Urol, 10.1016/j.eururo.2014.03.002 Shukla-Dave, 2012, Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer, BJU Int, 109, 1315, 10.1111/j.1464-410X.2011.10612.x